Related Experiment Video

Updated: Apr 15, 2026

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
08:24

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

7.6K

Stem cell therapy for chronic heart failure

Gregor Poglajen1, Bojan Vrtovec

  • 1aAdvanced Heart Failure and Transplantation Center, University Medical Center Ljubljana, Ljubljana, Slovenia bStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California, USA.

Current Opinion in Cardiology
|April 2, 2015
PubMed

Insights

Recent stem cell therapy for heart failure shows promise, with CD34 cells and cardiosphere-derived cells improving function in specific patient groups. Personalized approaches are key for future success in heart failure treatment.

Area of Science:

  • Cardiology
  • Regenerative Medicine
  • Biomedical Engineering

Background:

  • Heart failure remains a leading cause of morbidity and mortality worldwide.
  • Current treatments for heart failure have limitations, creating a need for novel therapeutic strategies.
  • Stem cell therapy has emerged as a promising approach to address myocardial damage and dysfunction.

Purpose of the Study:

  • To review recent advancements in clinical stem cell therapy for heart failure.
  • To focus on critical aspects including patient selection, types of stem cells used, and delivery methods.
  • To synthesize current evidence on the efficacy and challenges of stem cell applications in heart failure.

Main Methods:

  • Systematic review of recent clinical trials and studies on stem cell therapy in heart failure.
  • Analysis of data concerning different stem cell types (e.g., CD34 cells, cardiosphere-derived cells, mesenchymal stem cells).
  • Evaluation of outcomes related to myocardial performance, functional capacity, and scar burden reduction.

Main Results:

  • CD34 cell transplantation improved myocardial performance and functional capacity in non-ischemic heart failure.
  • Cardiosphere-derived cells reduced myocardial scar burden and increased viable tissue in ischemic heart failure.
  • Both autologous and allogeneic mesenchymal stem cells demonstrated efficacy in improving heart function in ischemic heart failure.

Conclusions:

  • Stem cell therapy trials for heart failure have yielded promising but inconsistent results.
  • A one-size-fits-all approach to stem cell therapy in heart failure is unlikely due to the condition's heterogeneity.
  • Future strategies should prioritize personalized medicine, optimizing stem cell type, dose, and delivery for individual patients and disease states.
Abstract

More Related Videos

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells09:05

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

Published on: August 9, 2017

11.5K
Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart11:45

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

7.1K

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.6K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
610
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K